Harold O Longe MD

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Medical Oncologist at Indiana University Health

10212 Lantern RdFishers, IN 46037
Phone+1 317-841-5656
Fax+1 317-841-5751

Dr. Longe is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Longe's full profile Already have an account?

Summary

Dr. Harold Longe is an oncology specialist based in Fishers, IN, with subspecialties in breast cancer, gastrointestinal cancer, hematologic oncology, and thoracic cancer. He completed his fellowship in Hematology and Medical Oncology at Boston University Medical Center. Dr. Longe has experience in clinical research related to breast cancer and thoracic oncology. He has been published in several journals, including a paper on tumor genomic profiling and another on T cell large granular lymphocytic leukemia. He has been involved in clinical trials, including one on Everolimus and Paclitaxel for advanced urothelial carcinoma. He received the CMS Meaningful Use Stage 1 Certification from iKnowMed EHR, McKesson in 2014-2015.

Education & Training

Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Woodhull Medical and Mental Health CenterResidency, Internal Medicine, 1993 - 1996
University of Ilorin Faculty of Health SciencesClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IN State Medical License 2009 - 2027
MA State Medical License 1996 - 2011
AR State Medical License 1999 - 2000
MI State Medical License 1996 - 1997
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2014-2015

Clinical Trials

First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
TERMINATED
PHASE2

Publications & Presentations

PubMed

Tumor Genomic Profiling to Determine Tissue Origin of Cancers of Unknown Primary: A Single Institute Experience With its Utility and Impact on Patient Management.
Omer A M Saeed, Ayşe Armutlu, Liang Cheng, Harold O Longe, Romil Saxena
Applied Immunohistochemistry & Molecular Morphology. 2022-10-01
T cell large granular lymphocytic leukemia, a rare form of post lung transplant lymphoproliferative disorder
Omer Saeed, Harold O. Longe, Jiehao Zhou
Annals of Hematology. 2018-01-08
36 citations
Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: Mechanism and therapeutic potential†
Harold O. Longe, Paul B. Romesser, Andrew M. Rankin, Douglas V. Faller, Mark S. Eller
International Journal of Cancer. 2009-01-15